Reviva Pharmaceuticals Holdings Inc.

NASDAQ:RVPH   4:00:00 PM EDT
3.62
+0.06 (+1.68%)
5:30:36 PM EDT: $3.86 +0.24 (+6.63%)
Earnings Announcements

Reviva Pharmaceuticals Holdings Inc Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:47 GMT
Reviva Pharmaceuticals Holdings Inc. (RVPH) - Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights.
Reviva Pharmaceuticals - As of September 30, 2022, Co's Cash Totaled About $23.2 Million Compared to About $29.7 Million As of December 31, 2021.
Reviva - Believes Co's Cash As of Sept 30, 2022 Will Be Sufficient to Fund Current Operating Plans Through at Least Nov 2023.
Reviva Pharmaceuticals Holdings, Inc. - Qtrly Loss per Share $0.18.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.